{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:33:29Z","timestamp":1775741609776,"version":"3.50.1"},"reference-count":27,"publisher":"Siapec Servizi Srl","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-1652","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:31:08Z","timestamp":1775737868000},"page":"580-587","source":"Crossref","is-referenced-by-count":0,"title":["Distinction of thymic carcinoma and type B3 thymoma using ancillary biomarkers"],"prefix":"10.32074","volume":"117","author":[{"given":"Anello Marcello","family":"Poma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Celi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Aprile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Stanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Bacchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Niccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Guida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelangelo","family":"Maestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello Carlo","family":"Ambrogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Lucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greta","family":"Al\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21774","published-online":{"date-parts":[[2026,2]]},"reference":[{"key":"10.32074\/1591-951X-1652_ref1","doi-asserted-by":"crossref","unstructured":"Roden, AC, Fang, W, Shen, Y, et al. Distribution of Mediastinal Lesions Across Multi-Institutional, International, Radiology Databases. Journal of Thoracic Oncology 2020;15:568-579 https:\/\/doi.org\/10.1016\/j.jtho.2019.12.108.","DOI":"10.1016\/j.jtho.2019.12.108"},{"key":"10.32074\/1591-951X-1652_ref2","doi-asserted-by":"crossref","unstructured":"Roden, AC, Ahmad U, Cardillo G, et al. Thymic Carcinomas\u2014A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group. Journal of Thoracic Oncology 2022;17:637-650, https:\/\/doi.org\/10.1016\/j.jtho.2022.01.021.","DOI":"10.1016\/j.jtho.2022.01.021"},{"key":"10.32074\/1591-951X-1652_ref3","doi-asserted-by":"crossref","unstructured":"Dadmanesh F, Sekihara T, Rosai J. Histologic Typing of Thymoma According to the New World Health Organization Classification. Chest Surg Clin N Am. 2001;11:407-420.","DOI":"10.1016\/S1052-3359(25)00577-0"},{"key":"10.32074\/1591-951X-1652_ref4","doi-asserted-by":"crossref","unstructured":"Wu J, Fang W, Chen G. The Enlightenments from ITMIG Consensus on WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting. J Thorac Dis. 2016;8:738-743, https:\/\/doi.org\/10.21037\/jtd.2016.01.84.","DOI":"10.21037\/jtd.2016.01.84"},{"key":"10.32074\/1591-951X-1652_ref5","doi-asserted-by":"crossref","unstructured":"Den Bakker MA, Marx A, Mukai K, et al. Mesenchymal Tumours of the Mediastinum\u2014Part I. Virchows Arch 2015;467:487-500 https:\/\/doi.org\/10.1007\/s00428-015-1830-8.","DOI":"10.1007\/s00428-015-1830-8"},{"key":"10.32074\/1591-951X-1652_ref6","doi-asserted-by":"crossref","unstructured":"Marx A, Chan JKC, Chalabreysse L, et al. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors? J Thorac Oncol 2022;17:200-213. https:\/\/doi.org\/ 10.1016\/j.jtho.2021.10.010.","DOI":"10.1016\/j.jtho.2021.10.010"},{"key":"10.32074\/1591-951X-1652_ref7","doi-asserted-by":"crossref","unstructured":"Radovich M, Pickering CR, Felau, I, et al. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell 2018;33:244-258.e10, https:\/\/doi.org\/10.1016\/j.ccell.2018.01.003.","DOI":"10.1016\/j.ccell.2018.01.003"},{"key":"10.32074\/1591-951X-1652_ref8","doi-asserted-by":"crossref","unstructured":"von der Th\u00fcsen J. Thymic epithelial tumours: histopathological classification and differential diagnosis. Histopathology 2024;84:196-215. https:\/\/doi.org\/ 10.1111\/his.15097.","DOI":"10.1111\/his.15097"},{"key":"10.32074\/1591-951X-1652_ref9","unstructured":"Hishima T, Fukayama M, Fujisawa M, et al. CD5 Expression in Thymic Carcinoma. Am J Pathol. 1994;145:268-275."},{"key":"10.32074\/1591-951X-1652_ref10","doi-asserted-by":"crossref","unstructured":"Pan C, Chen PC, Chiang H. KIT (CD117) Is Frequently Overexpressed in Thymic Carcinomas but Is Absent in Thymomas. The Journal of Pathology 2004;202:375-381 https:\/\/doi.org\/10.1002\/path.1514.","DOI":"10.1002\/path.1514"},{"key":"10.32074\/1591-951X-1652_ref11","unstructured":"Su X-Y, Wang W-Y, Li J-N, et al. Immunohistochemical Differentiation between Type B3 Thymomas and Thymic Squamous Cell Carcinomas. Int J Clin Exp Pathol. 2015;8:5354-5362."},{"key":"10.32074\/1591-951X-1652_ref12","doi-asserted-by":"crossref","unstructured":"Angirekula M, Chang SY, Jenkins SM, et al. CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma. Cancers 2022;14:2299 https:\/\/doi.org\/10.3390\/cancers14092299.","DOI":"10.3390\/cancers14092299"},{"key":"10.32074\/1591-951X-1652_ref13","doi-asserted-by":"crossref","unstructured":"Enkner F, Pichlh\u00f6fer B, Zaharie AT, et al. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets. Pathology and Oncology Research 2017;23:551-564 https:\/\/doi.org\/10.1007\/s12253-016-0144-8.","DOI":"10.1007\/s12253-016-0144-8"},{"key":"10.32074\/1591-951X-1652_ref14","doi-asserted-by":"crossref","unstructured":"Aesif SW, Aubry MC, Yi E.S, et al. Loss of P16 INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas. Journal of Thoracic Oncology 2017;12:860-871 https:\/\/doi.org\/10.1016\/j.jtho.2017.01.028.","DOI":"10.1016\/j.jtho.2017.01.028"},{"key":"10.32074\/1591-951X-1652_ref15","unstructured":"WHO Classification of Thoracic Tumors; 5th edition, IARC Publications, 2021; Vol. 5."},{"key":"10.32074\/1591-951X-1652_ref16","doi-asserted-by":"crossref","unstructured":"Berg KB, Dacic S, Miller C, et al A. Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas. Arch Pathol Lab Med 2018;142:1549-1553. https:\/\/doi.org\/ 10.5858\/arpa.2018-0273-OA.","DOI":"10.5858\/arpa.2018-0273-OA"},{"key":"10.32074\/1591-951X-1652_ref17","doi-asserted-by":"crossref","unstructured":"Hamasaki M, Matsumoto S, Abe S, et al. Low homozygous\/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma. Lung Cancer 2016; 99:155-61. https:\/\/doi.org\/ 10.1016\/j.lungcan.2016.07.011.","DOI":"10.1016\/j.lungcan.2016.07.011"},{"key":"10.32074\/1591-951X-1652_ref18","doi-asserted-by":"crossref","unstructured":"Louie BH, Kurzrock R. BAP1: Not just a BRCA1-associated protein. Cancer Treat Rev 2020;90:102091. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102091.","DOI":"10.1016\/j.ctrv.2020.102091"},{"key":"10.32074\/1591-951X-1652_ref19","doi-asserted-by":"crossref","unstructured":"Chapel DB, Hornick JL, Barlow J, et al. Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma. Mod Pathol. 2022;35:1383-1397 https:\/\/doi.org\/10.1038\/s41379-022-01081-z.","DOI":"10.1038\/s41379-022-01081-z"},{"key":"10.32074\/1591-951X-1652_ref20","doi-asserted-by":"crossref","unstructured":"Chapel DB, Schulte JJ, Berg K, et al. MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma. Mod Pathol. 2020;33:245-254 https:\/\/doi.org\/10.1038\/s41379-019-0310-0.","DOI":"10.1038\/s41379-019-0310-0"},{"key":"10.32074\/1591-951X-1652_ref21","doi-asserted-by":"crossref","unstructured":"Petrini I, Meltzer PS, Kim IK, et al. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat Genet 2014;46:844-9. https:\/\/doi.org\/10.1038\/ng.3016.","DOI":"10.1038\/ng.3016"},{"key":"10.32074\/1591-951X-1652_ref22","unstructured":"Marx A, Str\u00f6bel P, Badve SS, et al. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol 2014;9:596-611. https:\/\/doi.org\/ 10.1097\/JTO.0000000000000154."},{"key":"10.32074\/1591-951X-1652_ref23","doi-asserted-by":"crossref","unstructured":"Lyngg\u00e5rd LA, Panou V, Szejniuk W, et al. Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma. J Am Soc Cytopathol 2022;11:385-393, https:\/\/doi.org\/10.1016\/j.jasc.2022.07.003.","DOI":"10.1016\/j.jasc.2022.07.003"},{"key":"10.32074\/1591-951X-1652_ref24","doi-asserted-by":"crossref","unstructured":"Naso JR, Vrana JA, Koepplin JW, et al. EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma. Cancers (Basel) 2023;15:2274. https:\/\/doi.org\/10.3390\/cancers15082274.","DOI":"10.3390\/cancers15082274"},{"key":"10.32074\/1591-951X-1652_ref25","doi-asserted-by":"crossref","unstructured":"Petrini I, Meltzer PS, Zucali PA, et al. Copy number aberrations of BCL2 and CDKN2A\/B identified by array-CGH in thymic epithelial tumors. Cell Death Dis 2012;3:e351, https:\/\/doi.org\/10.1038\/cddis.2012.92.","DOI":"10.1038\/cddis.2012.92"},{"key":"10.32074\/1591-951X-1652_ref26","doi-asserted-by":"crossref","unstructured":"Naso JR, Jenkins SM, Vrana JA, et al. CD5 Immunoreactivity Is Associated With Longer Overall Survival in Thymic Carcinoma: A Brief Report. JTO Clinical and Research Reports 2025;6:100803, https:\/\/doi.org\/10.1016\/j.jtocrr.2025.100803.","DOI":"10.1016\/j.jtocrr.2025.100803"},{"key":"10.32074\/1591-951X-1652_ref27","doi-asserted-by":"crossref","unstructured":"Roden AC, Yi ES, Jenkins SM, et al. Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas. Hum Pathol 2015;46:17-25, https:\/\/doi.org\/10.1016\/j.humpath.2014.10.001.","DOI":"10.1016\/j.humpath.2014.10.001"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/1652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:32:56Z","timestamp":1775737976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pathologica.it\/article\/view\/1652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-1652","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"article-number":"5"}}